Jefferies lowers Charles River price target to $47.50

Charles River Laboratories International, Inc. was maintained by Jefferies & Co. Inc. analyst David Windley at a hold rating with a lowered price target to $47.50 from $49 after third-quarter results showed slow to no growth in two of the company's three segments, which caused Jefferies to lower forecasts for the rest of 2005, 2006 and 2007. Jefferies said it remains concerned about the company's ability to generate top-line growth. The Wilmington, Mass.-based company develops tools and services that enable drug development. Shares were up $0.13, or 0.30%, at $43.76 on volume of 537,800 shares versus the three-month running average of 680,723 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.